Type:
---AlogP:
2.64Polar Surface Area:
106.86HBA:
10HBD:
1#RO5 Violations:
1#Rotatable Bonds:
7Passes Ro3:
NQED Weighted:
0.35DETAILS
Type:
---AlogP:
4.82Polar Surface Area:
71.47HBA:
9HBD:
1#RO5 Violations:
1#Rotatable Bonds:
6Passes Ro3:
NQED Weighted:
0.36DETAILS
ALA5275086Name:
2-methylquinolin-8-yl 4-(bromomethyl)benzenesulfonateMol. Formula:
C17H14BrNO3SM.W.:
392.27Type:
---AlogP:
4.21Polar Surface Area:
56.26HBA:
4HBD:
---#RO5 Violations:
---#Rotatable Bonds:
4Passes Ro3:
NQED Weighted:
0.49DETAILS
Type:
---AlogP:
2.62Polar Surface Area:
62.68HBA:
9HBD:
---#RO5 Violations:
---#Rotatable Bonds:
5Passes Ro3:
NQED Weighted:
0.56DETAILS
ALA5273081Name:
5,7-dibromoquinolin-8-yl quinoline-8-sulfonateMol. Formula:
C18H10Br2N2O3SM.W.:
494.16Type:
---AlogP:
5.08Polar Surface Area:
69.15HBA:
5HBD:
---#RO5 Violations:
1#Rotatable Bonds:
3Passes Ro3:
NQED Weighted:
0.37DETAILS-
Type:
---AlogP:
4.93Polar Surface Area:
63.60HBA:
4HBD:
1#RO5 Violations:
---#Rotatable Bonds:
11Passes Ro3:
NQED Weighted:
0.22DETAILS - ALA5268190
Name:
quinolin-8-yl 4-(bromomethyl)benzenesulfonateMol. Formula:
C16H12BrNO3SM.W.:
378.25Type:
---AlogP:
3.90Polar Surface Area:
56.26HBA:
4HBD:
---#RO5 Violations:
---#Rotatable Bonds:
4Passes Ro3:
NQED Weighted:
0.51DETAILS -
Type:
---AlogP:
0.56Polar Surface Area:
46.61HBA:
3HBD:
---#RO5 Violations:
---#Rotatable Bonds:
---Passes Ro3:
YQED Weighted:
0.55DETAILS - ALA4797912
Name:
4-(5-(Benzamido)-1H-indol-1-yl)-N-methylpyridine-2-carboxamideMol. Formula:
C22H18N4O2M.W.:
370.41Type:
UnknownAlogP:
3.64Polar Surface Area:
76.02HBA:
4HBD:
2#RO5 Violations:
---#Rotatable Bonds:
4Passes Ro3:
NQED Weighted:
0.58DETAILS -
Type:
UnknownAlogP:
3.91Polar Surface Area:
114.05HBA:
7HBD:
3#RO5 Violations:
---#Rotatable Bonds:
7Passes Ro3:
NQED Weighted:
0.39DETAILS - ALA4797363
Name:
20-O-((2-fluorobenzoyl)carbamothioyl)glycinate-camptothecinMol. Formula:
C30H23FN4O6SM.W.:
586.60Type:
UnknownAlogP:
3.07Polar Surface Area:
128.62HBA:
9HBD:
2#RO5 Violations:
1#Rotatable Bonds:
5Passes Ro3:
NQED Weighted:
0.24DETAILS -
Type:
UnknownAlogP:
4.99Polar Surface Area:
105.34HBA:
6HBD:
3#RO5 Violations:
---#Rotatable Bonds:
8Passes Ro3:
NQED Weighted:
0.25DETAILS - ALA4796705
Name:
20-O-((thiophene-2-carbonyl)carbamothioyl)glycinate-camptothecinMol. Formula:
C28H22N4O6S2M.W.:
574.64Type:
UnknownAlogP:
3.00Polar Surface Area:
128.62HBA:
10HBD:
2#RO5 Violations:
1#Rotatable Bonds:
5Passes Ro3:
NQED Weighted:
0.24DETAILS -
Type:
UnknownAlogP:
5.21Polar Surface Area:
70.98HBA:
4HBD:
3#RO5 Violations:
1#Rotatable Bonds:
4Passes Ro3:
NQED Weighted:
0.36DETAILS - ALA4794668
Name:
20-O-(acetylcarbamothioyl)glycinate-camptothecinMol. Formula:
C25H22N4O6SM.W.:
506.54Type:
UnknownAlogP:
1.64Polar Surface Area:
128.62HBA:
9HBD:
2#RO5 Violations:
1#Rotatable Bonds:
4Passes Ro3:
NQED Weighted:
0.31DETAILS - ALA4794504
Name:
20-O-((2-phenylacetyl)carbamothioyl)glycinate-camptothecinMol. Formula:
C31H26N4O6SM.W.:
582.64Type:
UnknownAlogP:
2.86Polar Surface Area:
128.62HBA:
9HBD:
2#RO5 Violations:
1#Rotatable Bonds:
6Passes Ro3:
NQED Weighted:
0.23DETAILS - ALA4793468
Name:
20-O-((4-methoxybenzoyl)carbamothioyl)-L-methioninate-camptothecinMol. Formula:
C34H32N4O7S2M.W.:
672.78Type:
UnknownAlogP:
4.07Polar Surface Area:
137.85HBA:
11HBD:
2#RO5 Violations:
2#Rotatable Bonds:
9Passes Ro3:
NQED Weighted:
0.17DETAILS - ALA4791071
Name:
4-(5-(Benzenesulfonamido)-1H-indol-1-yl)-N-methylpyridine-2-carboxamideMol. Formula:
C21H18N4O3SM.W.:
406.47Type:
UnknownAlogP:
3.19Polar Surface Area:
93.09HBA:
5HBD:
2#RO5 Violations:
---#Rotatable Bonds:
5Passes Ro3:
NQED Weighted:
0.53DETAILS -
Type:
UnknownAlogP:
5.31Polar Surface Area:
76.02HBA:
4HBD:
2#RO5 Violations:
1#Rotatable Bonds:
4Passes Ro3:
NQED Weighted:
0.42DETAILS -
Type:
UnknownAlogP:
3.84Polar Surface Area:
105.34HBA:
6HBD:
3#RO5 Violations:
---#Rotatable Bonds:
8Passes Ro3:
NQED Weighted:
0.36DETAILS
The page will load shortly, Thanks for your patience!
Select all
